Evidence map›Paper›PMID 22189490›Full record

ReviewAnnals of biomedical engineering2012

Microfluidics for mammalian cell chemotaxis.

Beum Jun Kim, Mingming Wu

Abstract readReview
In one paragraph

Review in Annals of biomedical engineering, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 101 citations in OpenAlex.

  1. Review
  2. Frontiers in immunology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. COMethods and protocols · 2024
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Patterns of bacterial motility in microfluidics-confining environments.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  18. Microfabricated Devices for Confocal Microscopy on Biological Samples.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Beum Jun KimDepartment of Biological and Environmental Engineering, Cornell University, Ithaca, NY 14853, USA.
Mingming Wu
Cornell University · US

Funding

TRANS-NETWORK PROJECTSU54CA143876 · NCI · CORNELL UNIVERSITY · PI SHULER, MICHAEL L · 2009 to 2014
$12.6M
A 3D microfluidic platform for quantitative assessments of tumor cell migrationR21CA138366 · NCI · CORNELL UNIVERSITY · PI WU, MINGMING · 2010 to 2011
$347k
NCI NIH HHS R21 CA138366NCI NIH HHS R21CA138366NCI NIH HHS U54 CA143876NCI NIH HHS U54CA143876
6 · The paper itself

Abstract

The emerging field of micro-technology has opened up new possibilities for exploring cellular chemotaxis in real space and time, and at single cell resolution. Chemotactic cells sense and move in response to chemical gradients and play important roles in a number of physiological and pathological processes, including development, immune responses, and tumor cell invasions. Due to the size proximity of the microfluidic device to cells, microfluidic chemotaxis devices advance the traditional macro-scale chemotaxis assays in two major directions: one is to build well defined and stable chemical gradients at cellular length scales, and the other is to provide a platform for quantifying cellular responses at both cellular and molecular levels using advanced optical imaging systems. Here, we present a critical review on the designing principles, recent development, and potential capabilities of the microfluidic chemotaxis assay for solving problems that are of importance in the biomedical engineering field.

Indexed as

Cell Culture TechniquesChemotaxisMicrofluidic Analytical TechniquesMicrofluidicsAnimalsHumans

Identifiers

PMID22189490
PMCPMC3424276
OpenAlexW2018682190

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.